Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
MA 02 - Emerging Targets
- 11:00 - 12:30
- 10/16/2017
- Location: Room 511 + 512
- Type: Mini Oral
- Track: Clinical Design, Statistics and Clinical Trials
- Moderators:Ravi Salgia, Shun Lu
-
+
MA 02.12 - Discussant - MA 02.09, MA 02.10, MA 02.11
12:15 - 12:30 | Presenter: Dean A Fennell
- Abstract
No abstract available for this presentation
-
+
OA 02 - Mesothelioma: Challenges For New Treatment
- 11:00 - 12:30
- 10/16/2017
- Location: F205 + F206 (Annex Hall)
- Type: Oral
- Track: Mesothelioma
- Moderators:S. Hasegawa, Anna Nowak
-
+
OA 02.01 - Randomized Phase II Study of Anetumab Ravtansine or Vinorelbine in Patients with Malignant Pleural Mesothelioma
11:00 - 11:10 | Presenter: Hedy Lee Kindler | Author(s): Silvia Novello, Dean A Fennell, G. Blumenschein, A. Bearz, G.L. Ceresoli, J.G. Aerts, J. Spicer, P. Taylor, A. Greystoke, K. Nackaerts, Luana Calabro, S. Burgers, R. Jennens, A.F. Sporchia, A. Walter, J. Siegel, B.H. Childs, C. Elbi, R. Hassan
- Abstract
Loading...
-
+
P3.04 - Clinical Design, Statistics and Clinical Trials
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Clinical Design, Statistics and Clinical Trials
-
+
P3.04-013a - CONFIRM: A Phase III Randomized Trial to Evaluate the Efficacy of Nivolumab versus Placebo in Relapsed Mesothelioma
09:30 - 09:30 | Presenter: Dean A Fennell | Author(s): E.V. Kirkpatrick, K. Cozens, S. Danson, Gerard G Hanna, J.F. Lester, J. Lord, M. Nye, C. Ottensmeier, Peter Szlosarek, N. Steele, M. Kalevras, T. Maishman, G. Griffiths
- Abstract
Loading...
-
+
MA 19 - Mesothelioma: Bench to Bedside
- 11:00 - 12:30
- 10/18/2017
- Location: Room 315
- Type: Mini Oral
- Track: Mesothelioma
- Moderators:Dean A Fennell, Hedy Lee Kindler
-
+
MA 19.01 - A Phase II Study of Nivolumab: A Multicenter, Open-Label, Single Arm Study in Malignant Pleural Mesothelioma (MERIT)
11:00 - 11:05 | Presenter: Yasushi Goto | Author(s): Morihito Okada, T. Kijima, K. Aoe, Terufumi Kato, N. Fujimoto, Kazuhiko Nakagawa, Y. Takeda, T. Hida, K. Kanai, F. Imamura, S. Oizumi, T. Takahashi, M. Takenoyama, H. Tanaka, Yuichiro Ohe
- Abstract
Loading... -
+
MA 19.02 - Tremelimumab plus Durvalumab in First- or Second-Line Mesothelioma Patients: Final Analysis of the NIBIT-MESO-1 Study
11:05 - 11:10 | Presenter: Luana Calabro | Author(s): A. Morra, D. Giannarelli, G. Amato, E. Bertocci, A. D'Incecco, R. Danielli, L. Brilli, F. Giannini, M. Altomonte, A.M. Di Giacomo, M. Maio
- Abstract
Loading... -
+
MA 19.03 - Nintedanib + Pemetrexed/Cisplatin in Malignant Pleural Mesothelioma (MPM): Phase II Biomarker Data from the LUME‑Meso Study
11:10 - 11:15 | Presenter: Anna Nowak | Author(s): F. Grosso, N. Steele, Silvia Novello, Sanjay Popat, L. Greillier, T. John, Natasha B Leighl, Martin Reck, Nick Pavlakis, J.B. Sørensen, David Planchard, G.L. Ceresoli, B. Hughes, Julien Mazieres, Mark Socinski, A. Salnikov, T. Kitzing, J. Braunger, K. Pietzko, Giorgio Vittorio Scagliotti
- Abstract
Loading... -
+
MA 19.04 - Discussant - MA 19.01, MA 19.02, MA 19.03
11:15 - 11:30 | Presenter: Glen Reid
- Abstract
No abstract available for this presentation
-
+
MA 19.05 - Pegylated Arginine Deiminase Potentiates PD-1/PD-L1 Immune Checkpoint Blockade in Malignant Mesothelioma
11:30 - 11:35 | Presenter: Peter Szlosarek | Author(s): R. Khadeir, M. Sheaff, M. Locke, K. Lau, B. Wu, J. Bomalaski, S. Martin, S. Quezada
- Abstract
Loading... -
+
MA 19.06 - Multiple Mechanisms Contribute to Downregulation of Tumour Suppressor microRNAs in Malignant Pleural Mesothelioma
11:35 - 11:40 | Presenter: Marissa Williams | Author(s): Michaela B Kirschner, Yuen Yee Cheng, K.H. Sarun, B. McCaughan, S. Kao, Nico Van Zandwijk, Glen Reid
- Abstract
Loading... -
+
MA 19.07 - Does Loss of Smad7 Lead to Increased Aggressiveness of Malignant Pleural Mesothelioma?
11:40 - 11:45 | Presenter: Michael Grusch | Author(s): J. Gerstmayr, E. Lang, D. Falch, C. Pirker, V. Laszlo, B. Dome, W. Klepetko, Mir Alireza Hoda, W. Berger
- Abstract
Loading... -
+
MA 19.08 - Discussant - MA 19.05, MA 19.06, MA 19.07
11:45 - 12:00 | Presenter: Yoshitaka Sekido
- Abstract
No abstract available for this presentation
-
+
MA 19.09 - The Role of Neoadjuvant Chemotherapy in Patients with Malignant Pleural Mesothelioma
12:00 - 12:05 | Presenter: David Harpole | Author(s): S.L. Voigt, M. Joshi, P.J. Speicher, B.C. Tong, M.W. Onaitis, Jeffrey Crawford, Thomas D'Amico
- Abstract
Loading... -
+
MA 19.10 - Comparative Value of MR and CT for Tumor Volumetric and Clinical Staging of Malignant Pleural Mesothelioma
12:05 - 12:10 | Presenter: Ritu R Gill | Author(s): D. Murphy, R. Seethamraju, Raphael Bueno, W.G. Richards
- Abstract
Loading... -
+
MA 19.11 - Discussant - MA 19.09, MA 19.10
12:10 - 12:25 | Presenter: T. John
- Abstract
No abstract available for this presentation
-
+
MA 19.12 - Q&A
12:25 - 12:30
- Abstract
No abstract available for this presentation